Consortium

Partners

The ERA4TB Consortium brings together a multi-disciplinary team with proven expertise and capabilities in TB drug development to profile and progress anti-TB compounds up to completion of Phase I.

The project consortium integrates 31 organizations, namely eight prestigious academic institutions (UC3M, UNIZAR, UU, EPFL, UKÖ, UNIPD, UPV, LUND), four non-profit organizations (IPP, IPL, iM4TB, BAR), eight public research organizations (FZB, CNR, IDMIT, SERMAS, PHE, NICE, SCI, IOS) and five highly skilled small-medium enterprises (SYNAPSE, C-Path, IBT, QPS, GRIT42), together with three EFPIA members (GSK, EVT, JANSSEN), and three IMI2 Associated Partners (BMGF, TBA, DDU).

UC3M
University Carlos III Madrid
Website

IPP
Institute Pasteur (Paris)
Website

UNIZAR
University of Zaragoza Website
ARAID
ARAID Foundation Website

IPL
Institute Pasteur de Lille Foundation
Website

SYNAPSE
Synapse Research Management Partners
Website

BOR
Forschungszentrum Borstel
Website

IM4TB
Foundation Innovative Medicines for Tuberculosis
Website

C-PATH
Critical Path Institute, Limited
Website

CNR
Consiglio Nazionale delle Richerche
Website

IDMIT
Infectious Diseases Models for Innovative Therapies
Website

SERMAS
Instituto de Investigación Hospital Universitario La Paz
Website

UU
Uppsala University
Website

PHE
Public Health England- Department of Health
Website

EPFL
École polytechnique fédérale de Lausanne
Website

UKÖ
University of Köln
Website

UNIPD
University of Padova
Website

UPV
University of Pavia
Website

NICE
The National Institute for Health and Care Excellence
Website

IBT
ImaBiotech
Website

SCI
Sciensano
Website

LIOS
Latvia Institute of Organic Synthesis
Website

BAR
Bioaster Foundation de Coopération Scientifique
Website

QPS
QPS Netherlands BV
Website

LUND
Lund University
Website

GSK
Glaxosmithkline Investigacion y Desarrollo SL
Website

EVOTEC
Evotec International GmbH
Website

JANSSEN
Janssen Pharmaceutica NV
Website

BMGF
Bill & Melinda Gates Foundation
Website

TBA
TB Alliance
Website

DDU
University of Dundee
Website

GRIT42
Scientific Data Insights
Website

Collaborating Partners

Coming Soon

Advisors

Coming Soon

Know how accelerate the development of new treatment regimens for tuberculosis, discover our project

The Project